Pub Date : 2026-02-06DOI: 10.1016/j.anorl.2026.01.004
A Dubray-Vautrin, N Badois, O Choussy, M Lesnik
{"title":"An unusual velar ulceration?","authors":"A Dubray-Vautrin, N Badois, O Choussy, M Lesnik","doi":"10.1016/j.anorl.2026.01.004","DOIUrl":"https://doi.org/10.1016/j.anorl.2026.01.004","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-06DOI: 10.1016/j.anorl.2026.01.003
R Haddad, A Mattei, A Giovanni
Introduction: Injection laryngoplasty with hyaluronic acid (HA) is currently the first-line treatment for glottic insufficiency, significantly improving vocal function. Some rare inflammatory laryngeal reactions have been reported, managed conservatively by corticosteroids and antibiotics.
Case report: An 83-year-old woman with longstanding dysphonia due to left laryngeal paralysis was treated by medialization with hyaluronic acid injection under local anesthesia. Postoperative course featured onset of dyspnea 42h after injection, with a large laryngeal edema, unimproved by conservative medical treatment. CT showed edematous infiltration of the left hemilarynx, greater than the injected volume. Given the lack of clinical improvement, emergency tracheotomy was performed. Progressive absorption of the edema allowed decannulation 3weeks later.
Discussion: We report a rare complication after medialization by HA injection: a severe inflammatory laryngeal reaction significantly impairing airway function and threatening vital prognosis. The case highlights the critical need for close monitoring after medialization and for appropriate management in case of dyspnea onset.
{"title":"Inflammatory laryngeal reaction after medialization by hyaluronic acid.","authors":"R Haddad, A Mattei, A Giovanni","doi":"10.1016/j.anorl.2026.01.003","DOIUrl":"https://doi.org/10.1016/j.anorl.2026.01.003","url":null,"abstract":"<p><strong>Introduction: </strong>Injection laryngoplasty with hyaluronic acid (HA) is currently the first-line treatment for glottic insufficiency, significantly improving vocal function. Some rare inflammatory laryngeal reactions have been reported, managed conservatively by corticosteroids and antibiotics.</p><p><strong>Case report: </strong>An 83-year-old woman with longstanding dysphonia due to left laryngeal paralysis was treated by medialization with hyaluronic acid injection under local anesthesia. Postoperative course featured onset of dyspnea 42h after injection, with a large laryngeal edema, unimproved by conservative medical treatment. CT showed edematous infiltration of the left hemilarynx, greater than the injected volume. Given the lack of clinical improvement, emergency tracheotomy was performed. Progressive absorption of the edema allowed decannulation 3weeks later.</p><p><strong>Discussion: </strong>We report a rare complication after medialization by HA injection: a severe inflammatory laryngeal reaction significantly impairing airway function and threatening vital prognosis. The case highlights the critical need for close monitoring after medialization and for appropriate management in case of dyspnea onset.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146138006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-04DOI: 10.1016/j.anorl.2025.12.002
S Moon, E Shin, J W Kang
{"title":"Unilateral epistaxis and nasal obstruction in a middle-aged woman.","authors":"S Moon, E Shin, J W Kang","doi":"10.1016/j.anorl.2025.12.002","DOIUrl":"https://doi.org/10.1016/j.anorl.2025.12.002","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.anorl.2025.06.003
K. Al Tabaa , L. Morin , B. Faucon
{"title":"What happened to the capsule?","authors":"K. Al Tabaa , L. Morin , B. Faucon","doi":"10.1016/j.anorl.2025.06.003","DOIUrl":"10.1016/j.anorl.2025.06.003","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Pages 70-71"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.anorl.2025.09.002
M. Perréard, I. Huet, C. Legrais, E. Babin
{"title":"French campaign for laryngectomees’ quality of life","authors":"M. Perréard, I. Huet, C. Legrais, E. Babin","doi":"10.1016/j.anorl.2025.09.002","DOIUrl":"10.1016/j.anorl.2025.09.002","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Pages 75-76"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/S1879-7296(26)00014-1
{"title":"Thanks to reviewers","authors":"","doi":"10.1016/S1879-7296(26)00014-1","DOIUrl":"10.1016/S1879-7296(26)00014-1","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Page 77"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145982070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.anorl.2025.07.003
L. de Villars , M. Douet , C. Aussedat
Introduction
HEC® phenazone-tannin-witch hazel ointment is widely used in the treatment of epistaxis, with few adverse effects. Anaphylactic shock after packing with HEC® ointment has, to the authors’ knowledge, never previously been reported.
Case report
A 53 year-old male presented with massive epistaxis requiring packing after cauterization. After packing with HEC® ointment, the patient experienced grade 5 anaphylactic shock, requiring admission to intensive care. The outcome was ultimately favorable.
Conclusion
Potential allergy to the ingredients of HEC® ointment should be ascertained before application, to avoid serious reactions.
{"title":"Anaphylactic shock induced by HEC® ointment: A CARE case report","authors":"L. de Villars , M. Douet , C. Aussedat","doi":"10.1016/j.anorl.2025.07.003","DOIUrl":"10.1016/j.anorl.2025.07.003","url":null,"abstract":"<div><h3>Introduction</h3><div>HEC® phenazone-tannin-witch hazel ointment is widely used in the treatment of epistaxis, with few adverse effects. Anaphylactic shock after packing with HEC® ointment has, to the authors’ knowledge, never previously been reported.</div></div><div><h3>Case report</h3><div>A 53 year-old male presented with massive epistaxis requiring packing after cauterization. After packing with HEC® ointment, the patient experienced grade 5 anaphylactic shock, requiring admission to intensive care. The outcome was ultimately favorable.</div></div><div><h3>Conclusion</h3><div>Potential allergy to the ingredients of HEC® ointment should be ascertained before application, to avoid serious reactions.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Pages 56-57"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144805077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.anorl.2025.08.003
A. Ferney , T. Ferney , A. Lazard , S. Schmerber , E. Gay , R. Quatre
Aim
This study aimed to assess long-term progression of residual tumor and facial function after primary partial resection of large vestibular schwannoma.
Materials and methods
This retrospective study was performed in a tertiary reference center between January 2008 and December 2021. Patients with vestibular schwannoma exceeding 25 mm on the long axis underwent partial tumor resection, leaving a residual fragment, and were followed up for at least 3 years. The residue was confirmed on MRI at 6 months. Facial grade was assessed on the House-Brackmann classification at the immediate postoperative time-point and at 1 year.
Results
Fifty-seven patients were included: 10 (17%) showed tumor regrowth, at a mean 53 ± 25.5 months. Forty (70%) showed facial grades ≤ III at the immediate postoperative time, and 51 (89%) at 1 year. Mean residual tumor size was 13.6 ± 7.2 mm in patients with regrowth and 7.4 ± 5 mm in those without (P < 0.01). On multivariate analysis, only residual tumor size was significantly associated with regrowth (OR = 1.263; 95% CI [1.050–1.677]; P = 0.04). ROC analysis identified a 6.5 mm threshold for residual tumor size, beyond which risk of regrowth increased, with 90% sensitivity, 53% specificity and 0.78 AUC.
Conclusion
Partial resection of large vestibular schwannoma provided satisfactory control and only mild postoperative facial palsy. Small residual tumor size was the main factor for success.
{"title":"Long-term follow-up of residual tumor and facial function after partial resection of vestibular schwannoma","authors":"A. Ferney , T. Ferney , A. Lazard , S. Schmerber , E. Gay , R. Quatre","doi":"10.1016/j.anorl.2025.08.003","DOIUrl":"10.1016/j.anorl.2025.08.003","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to assess long-term progression of residual tumor and facial function after primary partial resection of large vestibular schwannoma.</div></div><div><h3>Materials and methods</h3><div>This retrospective study was performed in a tertiary reference center between January 2008 and December 2021. Patients with vestibular schwannoma exceeding 25<!--> <!-->mm on the long axis underwent partial tumor resection, leaving a residual fragment, and were followed up for at least 3 years. The residue was confirmed on MRI at 6 months. Facial grade was assessed on the House-Brackmann classification at the immediate postoperative time-point and at 1 year.</div></div><div><h3>Results</h3><div>Fifty-seven patients were included: 10 (17%) showed tumor regrowth, at a mean 53<!--> <!-->±<!--> <!-->25.5 months. Forty (70%) showed facial grades<!--> <!-->≤<!--> <!-->III at the immediate postoperative time, and 51 (89%) at 1 year. Mean residual tumor size was 13.6<!--> <!-->±<!--> <!-->7.2<!--> <!-->mm in patients with regrowth and 7.4<!--> <!-->±<!--> <!-->5<!--> <!-->mm in those without (<em>P</em> <!--><<!--> <!-->0.01). On multivariate analysis, only residual tumor size was significantly associated with regrowth (OR<!--> <!-->=<!--> <!-->1.263; 95% CI [1.050–1.677]; <em>P</em> <!-->=<!--> <!-->0.04). ROC analysis identified a 6.5<!--> <!-->mm threshold for residual tumor size, beyond which risk of regrowth increased, with 90% sensitivity, 53% specificity and 0.78 AUC.</div></div><div><h3>Conclusion</h3><div>Partial resection of large vestibular schwannoma provided satisfactory control and only mild postoperative facial palsy. Small residual tumor size was the main factor for success.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Pages 19-23"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.anorl.2025.06.008
P. Toulemonde , F. Giraudet , J. Macario , V. Krause , C. Vincent
Objective
This study aimed to evaluate the psychometric function curve and signal-to-noise ratio (SNR) loss values during the “Vocale Rapide dans le Bruit” (VRB) speech-in-noise test with speech level presentations at 65 dB SPL (VRB65) and 45 dB SPL (VRB45) in normal-hearing subjects.
Materials and methods
Adult normal-hearing subjects underwent an audiological evaluation including tympanometry, pure-tone audiometry, speech recognition threshold in silence and speech-in-noise audiometry following the recommended protocol (65 dB SPL, VRB65), followed by a second series of tests with a lower sentence presentation level (45 dB SPL, VRB45).
Results
Among the 29 normal-hearing subjects, there was no significant variation in the psychometric function curves or SNR loss values for VRB65 or VRB45.
Conclusion
The “Vocale Rapide dans le Bruit” speech-in-noise test is a relevant tool for assessing auditory difficulties in noisy environments. In normal-hearing subjects, presenting sentences at different intensity levels did not show a significant difference. This was an essential prerequisite for its use at various signal presentation levels, which could enable the evaluation of the functional state of high- and low-threshold auditory nerve fibers. This, in turn, would refine clinical diagnosis and improve the management of hearing disorders associated with hidden hearing loss.
目的：研究正常听力受试者在语音水平为65dB SPL （VRB65）和45dB SPL （VRB45）的情况下进行“快速声跳”（Vocale Rapide dans le Bruit， VRB）语音噪声测试时的心理测量函数曲线和信噪比损失值。材料和方法：成年正常听力受试者按照推荐方案（65dB SPL, VRB65）进行听力学评估，包括鼓室测听、纯音测听、无声语音识别阈值测听和噪声语音测听，然后进行第二组较低句子呈现水平的测试（45dB SPL, VRB45）。结果：29名听力正常受试者中，VRB65和VRB45的心理功能曲线和信噪比损失值无显著差异。结论：“Vocale Rapide dans le Bruit”噪声语音测试是评估噪声环境下听觉困难的有效工具。在听力正常的被试中，不同强度的句子呈现没有显著差异。这是在各种信号呈现水平下使用该方法的必要前提，从而能够评估高阈值和低阈值听神经纤维的功能状态。反过来，这将改进临床诊断并改善与隐性听力损失相关的听力障碍的管理。
{"title":"Speech audiometry in noise: Signal noise ratio loss values according speech signal level presentation in normal hearing subjects","authors":"P. Toulemonde , F. Giraudet , J. Macario , V. Krause , C. Vincent","doi":"10.1016/j.anorl.2025.06.008","DOIUrl":"10.1016/j.anorl.2025.06.008","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to evaluate the psychometric function curve and signal-to-noise ratio (SNR) loss values during the “Vocale Rapide dans le Bruit” (VRB) speech-in-noise test with speech level presentations at 65<!--> <!-->dB SPL (VRB65) and 45<!--> <!-->dB SPL (VRB45) in normal-hearing subjects.</div></div><div><h3>Materials and methods</h3><div>Adult normal-hearing subjects underwent an audiological evaluation including tympanometry, pure-tone audiometry, speech recognition threshold in silence and speech-in-noise audiometry following the recommended protocol (65<!--> <!-->dB SPL, VRB<sub>65</sub>), followed by a second series of tests with a lower sentence presentation level (45<!--> <!-->dB SPL, VRB<sub>45</sub>).</div></div><div><h3>Results</h3><div>Among the 29 normal-hearing subjects, there was no significant variation in the psychometric function curves or SNR loss values for VRB<sub>65</sub> or VRB<sub>45</sub>.</div></div><div><h3>Conclusion</h3><div>The “Vocale Rapide dans le Bruit” speech-in-noise test is a relevant tool for assessing auditory difficulties in noisy environments. In normal-hearing subjects, presenting sentences at different intensity levels did not show a significant difference. This was an essential prerequisite for its use at various signal presentation levels, which could enable the evaluation of the functional state of high- and low-threshold auditory nerve fibers. This, in turn, would refine clinical diagnosis and improve the management of hearing disorders associated with hidden hearing loss.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 1","pages":"Pages 14-18"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号